-+ 0.00%
-+ 0.00%
-+ 0.00%

Knight Therapeutics signs exclusive Latin America distribution deal with Kyowa Kirin for Poteligeo

PUBT·09/29/2026 11:33:42
Listen to the news
Knight Therapeutics signs exclusive Latin America distribution deal with Kyowa Kirin for Poteligeo
  • Knight Therapeutics signed an exclusive distribution deal with Kyowa Kirin International for mogamulizumab (Poteligeo) in Latin America.
  • Knight will seek regulatory approvals, then commercialize the drug in Brazil, Mexico, Colombia, Argentina.
  • Poteligeo treats relapsed or refractory mycosis fungoides or Sézary syndrome, two common cutaneous T-cell lymphoma subtypes.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Knight Therapeutics Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202609290730PRIMZONEFULLFEED9835239) on September 29, 2026, and is solely responsible for the information contained therein.